NCT06557915

Brief Summary

The goal of this study is to Detect and Screen different nasal complications of using CPAP in neonates and infants and reach a consensus about minimizing nasal problems of CPAP in neonates and infants

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 16, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 16, 2024

Status Verified

August 1, 2024

Enrollment Period

1 year

First QC Date

August 14, 2024

Last Update Submit

August 14, 2024

Conditions

Keywords

neonatesCPAP

Outcome Measures

Primary Outcomes (1)

  • Detection of different nasal complications of using CPAP in neonates and infants

    the metric used is complete ENT examination of neonates and infants subjected to CPAP

    1 week following using CPAP in neonates and infants

Study Arms (1)

Neonates and Infants Subjected to CPAP

* Detection and Screening of different nasal complications of using CPAP in neonates and infants * reach a consensus about minimizing nasal problems of CPAP in neonates and infants

Procedure: screening

Interventions

screeningPROCEDURE

screening and detection of nasal problems in Neonates and Infants Subjected to CPAP

Neonates and Infants Subjected to CPAP

Eligibility Criteria

Age1 Day - 1 Year
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

All neonates (full and preterm), infants (less than 1 year) subjected to CPAP with different indications

You may qualify if:

  • Neonates and infants subjected to CPAP and presented to ENT department for assessment of nasal condition

You may not qualify if:

  • Failure to obtain consent.
  • Children above 1 year
  • Adults

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, Sohag University

Sohag, 82511, Egypt

Location

MeSH Terms

Interventions

Mass Screening

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDiagnostic ServicesPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health Practice

Study Officials

  • Ahmed Abdelaal

    faculty of medicine,sohag university

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Evaluation of nasal problems in neonates and infants subjected to CPAP in Sohag University hospitals

Study Record Dates

First Submitted

August 14, 2024

First Posted

August 16, 2024

Study Start

October 1, 2024

Primary Completion

October 1, 2025

Study Completion

December 1, 2025

Last Updated

August 16, 2024

Record last verified: 2024-08

Locations